Hepatitis B Foundation Press Releases
The Hepatitis B Foundation is happy to assist the media in reporting on the impact of hepatitis B worldwide. We can coordinate interviews with experts in research, public health, community outreach efforts, and immunization and treatment initiatives.
2018 Press Releases
Hepatitis B Foundation Calls for Universal Screening for Hepatitis B
In recognition of World Hepatitis Day on July 28, the Hepatitis B Foundation (HBF) is calling for all Americans to be tested for hepatitis B infection. The formal recommendation was approved by HBF’s Scientific and Medical Advisory Board to achieve the World Health Organization’s (WHO) ambitious goal of eliminating hepatitis B by the year 2030. Read more.
Hepatitis B Leaders Call for the Elimination of Hepatitis B
Hep B United, a national coalition established by the Hepatitis B Foundation (HBF) and the Association of Asian Pacific Community Health Organizations (AAPCHO) to address the silent epidemic of hepatitis B, hosts its sixth annual summit in Washington, D.C., July 24 to 26. The summit brings together community leaders, advocates and people with hepatitis B to promote screening and prevention strategies and advocate for equitable access to health care to further its mission to eliminate hepatitis B in the United States. Read more.
Hepatitis B Foundation Releases New #justB Stories to Empower People Affected by Hepatitis B, Raise Awareness and End Stigma
The Hepatitis B Foundation released seven new videos as part of its national #justB storytelling campaign, which was launched one year ago to highlight the personal stories of people from across the United States who have been affected by hepatitis B. Read more
Hepatitis B Foundation Honors Business Leader Fred Beans and Scientist Ding-Shinn Chen at its 2018 Crystal Ball Gala
The Hepatitis B Foundation (HBF) hosted over 230 leaders from academia, industry, government and the community at its annual Crystal Ball Gala on April 6, 2018 at Pinecrest Country Club in Lansdale, PA. Read more.
New Two-Dose HBV Vaccine Recommended by ACIP
February 22, 2018: The Advisory Committee on Immunization Practices’ (ACIP) voted today to unanimously recommend HEPLISAV-B™ for use among individuals age 18 years and older to prevent hepatitis B infection (HBV). The Hepatitis B Foundation welcomes the use of the new vaccine, which is expected to increase immunization rates for adults in the United States. Read more.
2017 Press Releases
Timothy M. Block, PhD, President of Hepatitis B Foundation and its Baruch S. Blumberg Institute, named a 2017 National Academy of Inventors Fellow 2017
December 12, 2017: Timothy M. Block, Ph.D, has been named a Fellow of the US National Academy of Inventors (NAI), the organization announced Tuesday. Dr. Block is President of the Hepatitis B Foundation, as well as its research arm, the Baruch S. Blumberg Institute, and its Pennsylvania Biotechnology Center. Read more.
Hepatitis B Foundation Applauds FDA Approval of New Hepatitis B Vaccine
November 2017: Today on World Immunization Day, the Hepatitis B Foundation applauded the U.S. Food and Drug Administration’s (FDA) approval of HEPLISAV-B™, the first new hepatitis B vaccine in more than 25 years and the only two-dose schedule for the prevention of infection in adults. Read more.
CDC National Progress Report on Hepatitis Elimination Reveals Rise in Acute HBV Infections and Low Birth Dose Vaccination Rates in the U.S.
October 2017: The Hepatitis B Foundation statement on the CDC's national progress report on viral hepatitis elimination in the U.S., which measures progress toward 2020 goals. Read more.
Hepatitis B Foundation Announces Promotion of Chari Cohen, DrPH, MPH, to Vice President, Public Health and Programs
October 2017: The Hepatitis B Foundation, a national nonprofit organization headquartered in Doylestown, PA, has announced the promotion of Chari Cohen, DrPH, MPH to vice president, public health and programs. Read more.
Hepatitis B Foundation Mourns the Loss of Pioneering Hepatitis B Physician-Scientist Dr. W. Thomas London
June 2017: W. Thomas London, MD, an internationally renowned physician-scientist dedicated to the study of hepatitis B, passed away June 3 at the age of 85. Dr. London was a key member of the research team that discovered the hepatitis B virus in the early 1960s, and longtime member of the Board of the Hepatitis B Foundation and its research arm, the Baruch S. Blumberg Institute, where he also served as a distinguished scientific and medical advisor. Read more.
Hepatitis B Foundation Launches Hep B Cure Campaign for Increased NIH Funding
May 2017: The Hepatitis B Foundation launches its national Hep B Cure Campaign, which features a consensus research agenda that outlines top scientists’ priority research recommendations for hepatitis B and liver cancer. Read more.
Hepatitis B Foundation's #justB Campaign Gives Voice to Personal Stories During May Hepatitis Awareness Month
May 2017: The Hepatitis B Foundation has launched its innovative #justB Storytelling Campaign to highlight the personal stories of people affected by hepatitis B to capture public attention during May Hepatitis Awareness Month. Read more.
Hepatitis B Foundation Executive Director Retires After 25 Years of Service
April 2017: Co-founder Joan Block helped create the nation’s leading nonprofit research and disease advocacy organization dedicated to hepatitis B. Read more.
Hepatitis B Foundation Commends Targets to Eliminate Hepatitis B in U.S.
March 2017: The Hepatitis B Foundation commends the U.S. National Academies of Sciences, Engineering, and Medicine (NASEM) report, A National Strategy for the Elimination of Hepatitis B and C: Phase Two Report, that concludes a 50 percent reduction in mortality from chronic hepatitis B infection, as well as elimination of mother-to-child transmission of hepatitis B, is possible in the United States by 2030with appropriate prioritization and resources. Read more.
Hepatitis B Foundation and HBV Forum Summary Report of Meeting with US FDA
March 2017: Representatives from the Hepatitis B Foundation and HBV Forum met with representatives from the US FDA to discuss clinical development of hepatitis B therapeutics. Read the meeting summary.
Fred Beans Family of Dealerships Donates $30,000 to Support the Hepatitis B Foundation's High School Enrichment Programs
February 2017: The Hepatitis B Foundation’s (HBF) High School Science Enrichment Program received a $30,000 donation from the Fred Beans Family of Dealerships to support its research program for outstanding high school students. Read more.
Hepatitis B Foundation Welcomes International Leaders to Its Scientific and Medical Advisory Board
February 2017: The Hepatitis B Foundation is pleased to announce that two internationally renowned experts in the area of viral hepatitis have joined its Scientific and Medical Advisory Board. Read more.
Hepatitis B Foundation Appoints Global Expert Dr. Nat Brown to Its Board of Directors
February 2017: The Hepatitis B Foundation, the nation’s leading nonprofit research and disease advocacy organization, is pleased to announce the appointment of Nathaniel Brown, M.D., a retired pharmaceutical executive living in San Francisco, to its Board of Directors. Read more.
Hepatitis B Foundation Launches #justB Storytelling Campaign
January 2017: The Hepatitis B Foundation unveils its #justB national storytelling campaign with real people sharing their stories about hepatitis B. The goal is to put a human face on this disease in order to increase public awareness, decrease stigma and discrimination, and to promote testing and treatment for hepatitis B, which will ultimately save lives. Read more.
World-Renowned Cancer Physician Scientist Dr. Richard G. Pestell Joins the Baruch S. Blumberg Institute
January 2017: World-renowned cancer physician scientist Richard G. Pestell, M.D., Ph.D., has joined the Baruch S. Blumberg Institute to serve as President of the Pennsylvania Cancer and Regenerative Medicine Research Center (PCARM). Read more.
2016 Press Releases
Hepatitis B Research Pioneer Dr. Bud Tennant Leaves Behind a Distinguished Scientific Legacy
November 2016: Bud C. Tennant, DVM,a pioneer in developing the woodchuck animal model for the study of hepatitis B, and distinguished member of the Hepatitis B Foundation’s Scientific and Medical Advisory Board, passed away on November 16. Read more.
Hepatitis B Foundation Co-Sponsors East Coast Film Premiere of Be About It
November 2016: Documentary about two families profoundly affected by hepatitis B will show at Philadelphia Asian American Film Festival on November 20. Read more.
Hepatitis B Foundation Launches Nationwide Hepatitis Delta Virus (HDV) Campaign to Expand Awareness and Testing for HDV Infection
October 2016: Collaboration with Eiger Biopharma and ARUP Laboratories Focuses on Deadly Form of Viral Hepatitis. Read more.
Living with Hepatitis B: Hepatitis B Foundation Launches Patient Storytelling Campaign
October 2016: National nonprofit creates program to help people living with hepatitis B share their stories. Read more.
Hepatitis B Foundation Applauds CMS Final Decision to Cover Hepatitis B Screening
September 2016: Hepatitis B screening test added as a preventive service for Medicare beneficiaries. Read more.
Hepatitis B Foundation Launches Comprehensive New Website to Celebrate 25th Anniversary
September 2016: National nonprofit’s new website offers improved user experience, simplified navigation as a trusted global authority for information about hepatitis B. Read more.
Baruch S. Blumberg Institute Congratulates Michael J. Sofia on Receiving the 2016 Lasker-DeBakey Clinical Medical Research Award
September 2016: Blumberg Institute professor receives celebrated scientific honor for his discovery of the cure for chronic hepatitis C infection. Read more.
Hepatitis B Foundation Partners with Eiger BioPharmaceuticals to Raise Awareness of Hepatitis Delta Virus Co-Infection
August 2016: Occurring only in those already infected with hepatitis B, hepatitis delta can lead to more severe liver disease than HBV alone. Read more.
‘Making the Link’ Between Viral Hepatitis and Liver Cancer
July 2016: Hepatitis B Foundation to urge Philadelphia city leaders to help decrease liver cancer rates by making chronic HBV and HCV testing and treatment a local priority. Read more.
Hepatitis B Foundation Marks 25th Anniversary at 2016 Crystal Ball Gala
April 2016: Annual event raises nearly $125,000 for research and outreach to eliminate hepatitis B that affects more than 12 million Americans and 2 billion people worldwide. Read more.
Hepatitis B Foundation’s ‘Nobel Challenge’ Raises $3 Million to Support Research for a Cure
Jan. 26 – The Hepatitis B Foundation announces the successful completion of its “Nobel Challenge” campaign, raising more than $3 million to recruit top scientists to its affiliated Baruch S. Blumberg Institute to fulfill its research mission - to find a cure for hepatitis B. Read more.
Baruch S. Blumberg Institute Partners with The Commonwealth Medical College to Offer Innovative Graduate Program
Jan. 14 - The Baruch S. Blumberg Institute, established by the Hepatitis B Foundation, announced today it will partner with The Commonwealth Medical College to offer the first life sciences graduate program in Bucks County, PA. Working professionals will be able to earn a Master's degree in Biological Sciences in 16 months during evening and weekend classes at the Blumberg Institute in Doylestown, PA. Read more.
Hepatitis B Foundation Leaders Help Shape National Plan to Eliminate Hepatitis B and C
Jan. 11, 2016 - Drs. Robert Gish and Chari Cohen of the Hepatitis B Foundation provide expert testimony to the National Academy of Medicine in support of a national strategy to eliminate chronic viral hepatitis in the United States by 2030. Read more.
Journal of the National Cancer Institute (JNCI) Publishes Summary of Hepatitis B Foundation’s Liver Cancer Workshop
Dec. 2015 - The JNCI paper submitted by the Hepatitis B Foundation in collaboration with thought leaders in the field focused on improving screening and care for those with liver cancer related to chronic hepatitis B infections. The article, “Hepatitis-Associated Liver Cancer: Gaps and Opportunities to Improve Care,” has been published online and will appear in the NCI Journal’s print issue in April 2016. Read more.
The W. Thomas London Distinguished Professorship Established by the Hepatitis B Foundation and Baruch S. Blumberg Institute
Oct. 2015 - The named Professorship honors Dr. W. Thomas London (on left) who made transformational contributions to the discovery of the hepatitis B virus with Dr. Baruch Blumberg and dedicated his career to the study of the virus and care of those affected. Dr. Ju Tao Guo (on right) is the inaugural recipient of the new professorship. He serves as director of Experimental Therapeutics at the Baruch S. Blumberg Institute, which was established by the Hepatitis B Foundation to fulfill its research mission. Read more.
2015 Press Releases
Dr. Eugene Schiff Receives Hepatitis B Foundation’s Highest Scientific Honor
April 20 – The 2015 Crystal Ball Gala, hosted by the Hepatitis B Foundation, was a huge success, and included an evening of dinner, dancing, live and silent auctions, a mission moment, and the awarding of the Baruch S. Blumberg Prize to Dr. Eugene Schiff for advancing the care and treatment of chronic hepatitis B. Read more.
Baruch S. Blumberg Institute Recruits World-Class Hepatitis B Scientists
March 2015 – The Baruch S. Blumberg Institute (www.blumberginstitute.org) has recruited a new team of nationally renowned scientists to focus exclusively on research to develop a cure for hepatitis B, a move that nearly triples its research capacity and has created the largest concentration of nonprofit scientists focusing solely on hepatitis B and liver cancer in the United States. Read more.
Hepatitis B Foundation Welcomes Two New Board Members
Jan 26 – The HBF is proud to announce that Craig Esterly, engineer and business owner, and Wayne Yetter, pharmaceutical industry executive, have joined its Board of Directors. Both bring broad and deep experience in the healthcare arena, and are joining the Foundation at a time when we are rapidly expanding and accelerating our pace of research into finding a cure for hepatitis B. Read more.